SCHEMBL12420282

SCHEMBL12420282

OB(O)c1ccc(-c2nnc(-c3cccc4c3C=CC4)o2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 15/20 0.36
▸ NPC1 O15118 14/20 0.36
▸ ALDH1A1 P00352 9/20 0.36
▸ SMN1; SMN2 Q16637 8/20 0.36
▸ HPGD P15428 7/20 0.36
▸ KDM4E B2RXH2 7/20 0.36
▸ TSHR P16473 5/20 0.36
▸ MAPT P10636 4/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ TP53 P04637 2/20 0.36
▸ NFKB1 P19838 2/20 0.36
▸ NFKB2 Q00653 2/20 0.36
▸ RELA Q04206 2/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ SENP8 Q96LD8 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36
▸ SENP6 Q9GZR1 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12419567 0.75 PARP1 (0.37) RAB9ANPC1ALDH1A1SMN1; SMN2HPGD
SCHEMBL12419559 0.72 RAB9A (0.53) RAB9ANPC1ALDH1A1SMN1; SMN2HPGD
SCHEMBL2816834 0.71 NPC1 (0.65) RAB9ANPC1ALDH1A1SMN1; SMN2HPGD
SCHEMBL12419558 0.71 STIM1 (0.39) RAB9ANPC1ALDH1A1SMN1; SMN2HPGD
SCHEMBL12419575 0.71 ALDH1A1 (0.44) RAB9ANPC1ALDH1A1SMN1; SMN2HPGD
SCHEMBL16488121 0.68 ATR (0.48) RAB9ANPC1ALDH1A1SMN1; SMN2HPGD
SCHEMBL12508694 0.68 SMN1; SMN2 (0.66) RAB9ANPC1ALDH1A1SMN1; SMN2HPGD
SCHEMBL12419574 0.68 NPC1 (0.52) RAB9ANPC1ALDH1A1SMN1; SMN2HPGD
SCHEMBL26606283 0.67 CA1 (0.34) ALDH1A1HPGDKDM4EHSD17B10CYP1A2
SCHEMBL12420280 0.67 MAOA (0.52) RAB9ANPC1ALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 — — US disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 RAB9A 1820/4885NPC1 472/4885ALDH1A1 354/4885
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 RAB9A 1820/4885NPC1 472/4885ALDH1A1 354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback